Growth Metrics

SOPHiA GENETICS (SOPH) Cash from Operations (2020 - 2025)

Historic Cash from Operations for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$8.7 million.

  • SOPHiA GENETICS's Cash from Operations fell 384.02% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.1 million, marking a year-over-year increase of 1723.69%. This contributed to the annual value of -$44.0 million for FY2024, which is 1610.74% up from last year.
  • SOPHiA GENETICS's Cash from Operations amounted to -$8.7 million in Q3 2025, which was down 384.02% from -$8.1 million recorded in Q2 2025.
  • SOPHiA GENETICS's Cash from Operations' 5-year high stood at -$8.1 million during Q2 2025, with a 5-year trough of -$23.1 million in Q3 2022.
  • In the last 5 years, SOPHiA GENETICS's Cash from Operations had a median value of -$12.6 million in 2023 and averaged -$13.3 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 7138.62% in 2022, then surged by 4403.92% in 2023.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Cash from Operations stood at -$15.4 million in 2021, then grew by 28.85% to -$11.0 million in 2022, then fell by 14.4% to -$12.6 million in 2023, then grew by 16.15% to -$10.5 million in 2024, then grew by 17.01% to -$8.7 million in 2025.
  • Its last three reported values are -$8.7 million in Q3 2025, -$8.1 million for Q2 2025, and -$10.7 million during Q1 2025.